Dr. Kamni Vijay is a distinguished leader in the life sciences and technology sectors, known for her ability to translate scientific advancements into impactful commercial solutions. Most recently, she served as Chief Executive Officer of Enable Medicine, a pioneering company leveraging AI and large-scale biological data to accelerate discoveries in precision medicine. Under her leadership, the company advanced AI-driven approaches to biological research and drug discovery, culminating in a successful exit. With over 25 years of experience spanning multinational businesses in life science tools, diagnostics, and healthcare, Kamni has held senior leadership roles at industry-leading companies such as Agilent Technologies, Bio-Rad Laboratories, Becton Dickinson, and Bio-Techne. At Becton Dickinson, she drove the development of innovative point-of-care diagnostic solutions and the related national reimbursement policy for critical platforms deployed during the COVID-19 pandemic. At Bio-Techne, she led and expanded the Spatial Biology business, driving the launch of transformative tools in spatial transcriptomics. Kamni is recognized for her contributions to the life sciences industry through her involvement with the senior executive ALDA association. A strong advocate for inclusive leadership, she served as Bio-Techne's first Executive Sponsor of Diversity and Belonging, helping foster a workplace culture that values diverse perspectives and experiences. She also brings boardroom experience from serving on corporate and advisory boards. Beyond her executive operating roles, Kamni has served as an Operating Partner at the venture firm Cota Capital, supporting companies within their portfolio. In addition, she continues to advise emerging companies at the intersection of AI/ML and precision oncology, providing strategic guidance to drive scientific and commercial breakthroughs. As a thought leader in the emerging field of TechBio, she collaborates with companies and investors to guide scientific and business strategy in precision oncology. Additionally, she serves in a scientific advisory capacity to diagnostics startups and local governments, contributing her expertise to novel public-private initiatives addressing the opioid epidemic. Kamni is widely recognized for her deep scientific acumen, business leadership, and commitment to driving innovative advancements that solve critical global challenges.
